ATP10B and Parkinson disease: Our genetics and functional data suggest that compound heterozygous ATP10B mutations contribute to risk for PD and DLB by a loss-of-function mechanism resulting in a dysregulated GluCer and PC homeostasis and lysosomal dysfunction.